The study compared retrospective data from three Atlanta hospitals that have a type 1 observation unit. Patients receiving observation status care in ED type 1 observation units saw a 23 to 28 percent shorter length of stay, 17 to 44 percent lower chance of readmission and $950 million potential national cost savings compared to observation patients treated elsewhere in the hospital.
The authors suggest that 11.7 percent of short stay patients nationwide could be treated in a type 1 observation unit, which they estimate could save $5.5 billion to $8.5 billion annually.
More Articles on Readmissions Studies:
Study: Hospitalist Presence Associated With Reduced Readmissions
Study: Patients With Dementia See Lower Readmission Rates When Discharged to Skilled Nursing Facility
Study: Medication Adherence Not Linked to Reduced Readmissions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
